View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
November 23, 2009

Beardsworth Opts For OmniComm’s TrialMaster Solution

For conducting a Phase II vaccine study

By CBR Staff Writer

Beardsworth has selected OmniComm Systems’ (OmniComm) TrialMaster EDC solution for conducting a Phase II vaccine study. The three-year, ten-site study is planning to enroll 340 subjects.

OmniComm and Beardsworth plan electronic imports of data to TrialMaster EDC, utilising OmniComm’s native, template matching subsystem. Electronic exports from TrialMaster EDC to Beardsworth’s BNet portal will be achieved utilising OmniComm’s new RESTful Web Services, Application Programming Interface (API).

Michael O’Brien, president and CEO of Beardsworth, said: After a careful selection process, we chose OmniComm Systems to be our preferred EDC provider.”

Stephen Johnson, COO of OmniComm, said: We look forward to working with Beardsworth on their next study and welcome them to our very successful CRO preferred program. We are pleased that OmniComm’s electronic data capture solution, TrialMaster, was chosen to capture and process the clinical trial data of this exciting vaccine study.

Content from our partners
Why the tech sector must embrace faster, smarter talent recruitment
Sherif Tawfik: The Middle East and Africa are ready to lead on the climate
What to look for in a modern ERP system

“TrialMaster will enable Beardsworth to confidently offer their clients an extensible, eClinical solution that will complement the outstanding services which have made their company a success.

Topics in this article :
Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how New Statesman Media Group may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
THANK YOU